Koehne, Charles F.; and O'Donnell, Paul V., "Influence of enhancer sequences on thymotropism and leukemogenicity of mink cell focus-forming viruses" (1989). Open Access Articles. 1583.
Mink cell focus-forming (MCF) retroviruses have been implicated as the proximal leukemogenic agents in the induction of spontaneous leukemia in certain inbred strains of mice (19, 21, 23, 34) . MCF viruses have been isolated from the thymus and other tissues of AKR mice during the preleukemic period (9, 10, 15, 16) . Some MCF isolates when injected into newborn animals accelerate the onset of leukemia (10, 34) . The ability to replicate to high titers in the thymus and express high levels of murine leukemia virus (MuLV)-related cell surface antigens on infected thymocytes is tightly correlated with the oncogenic phenotype of this class of MCF viruses (20, 28, 36, 37) . MCF 247 is the prototype of thymotropic, oncogenic MCF viral isolates (23) (24) (25) 34) .
MCF viruses with biological phenotypes distinct from those of MCF 247 have been isolated from thymocytes of preleukemic AKR mice (36, 37) . These viruses are unique because they replicate to high titer and express MuLVrelated cell surface antigens on infected thymocytes and do not accelerate the onset of leukemia in AKR mice. MCF 30-2 is the prototype of this class of MCF viruses (37) . Since previous studies showed that the ability of MCF as well as radiation-induced MuLV to replicate in thymocytes is positively correlated with the leukemogenic phenotype (10, 11) , the isolation of this class of viruses presents a paradox. We were interested in this paradox and have used MCF 30-2 as the prototype of this group of exceptional viruses to define the genetic determinants which distinguish it from MCF 247.
Studies using MCF 247, Friend, and Moloney MuLVs, as well as a number of other viruses have demonstrated that * Corresponding author.
MuLV enhancer elements, present as duplicated sequences within the long terminal repeats (LTRs) of these viruses, are important to the tissue tropism and oncogenic properties of these viruses (3-6, 12-14, 17, 24, 32, 33, 43, 46, 52) . To determine whether these or other sequences determine the difference in the oncogenic phenotypes of MCF 247 and MCF 30-2, we have cloned MCF 30-2, compared the viral genomes of MCF 30-2 and MCF 247, and constructed and characterized a set of recombinants between MCF 247 and MCF 30-2. We show here that the major differences between MCF 30-2 and MCF 247 are in the pl5E region of the env gene and in the LTR. In addition, we demonstrate that the differential virulence of MCF 30-2 and MCF 247 is due to sequences in the LTR.
MATERIALS AND METHODS
Molecular cloning of MCF 30-2. Hirt extracts of two separate cultures of Mus dunni cells infected with MCF virus were prepared, and molecular clones were isolated as described previously (25) . Briefly, viral DNA was digested with EcoRI and cloned into pBR322. Clones were identified by hybridization to 32P-labeled DNA from a molecular clone of MCF 247. Inserts from 10 clones were isolated, concatenated, and transfected into SC-1 or M. dunni cells (22, 31) . Medium from separate cultures transfected with 3 of the 10 molecular clones (p30-2-C1128-1, p30-2-1464-1, and p30-2-1464-8A) contains retroviral reverse transcriptase activity (1) . Two of the clones (p30-2-1464-1 and p30-2-1464-8A) were derived from a single Hirt extract, and the third (p30-2-C1128-1) was cloned from a separate infection. One clone, p30-2-1464-8A, was used to generate the site-specific recombinant viruses described below. The three clones of MCF 30-2 were mapped by digestion with 12 restriction enzymes (PstI, KpnI, SmaI, PvuI, PvuII, HindIll, Sau3A, XhoI, ClaI, HpaI, EcoRI, and XbaI).
Construction of recombinants. Recombinants were constructed as described previously (25) . Restriction sites used to generate recombinants were conserved in both MCF 30-2 and MCF 247 (7, 8) . The structures of the recombinants were verified by using unique restriction sites diagnostic for the fragments present in recombinants. MCF 247 has a unique EcoRI site in the LTR (7, 8) . This site is not present in the LTR of MCF 30-2 (data not shown). The structures of the recombinant viruses produced after transfection of the clones were confirmed by digesting viral intermediates with EcoRI and analyzing the digest with a Southern blot. All recombinants with an LTR of MCF 247 consistently contained an EcoRI site, whereas the site was absent from recombinants with an MCF 30-2 LTR. In some cases, the structures of the recombinants were confirmed by analyzing RNase T1 fingerprints of viruses produced after transfection of the recombinants. The fingerprints were analyzed for the presence or absence of the unique MCF 247 or MCF 30-2 RNase Tl-resistant oligonucleotides in the precursor to the piSE gene (PrplSE gene) (29, 34) .
Two independent clones of MCF 247 were used to generate the recombinants. One, p247-W, produced infectious virus when transfected into M. dunni cells as described previously (25) . Another molecular clone of MCF 247 (p247-lb) did not produce infectious virus when transfected. The LTR of p247-lb was biologically functional when used to generate an infectious recombinant and has been sequenced (29) .
Viruses and viral assays. Infectious viruses were generated from the DNA constructs of parental viruses or recombinants after DNA transfection into M. dunni cells. These cells are permissive for the replication of MCF viruses (31) . The presence of infectious virus in culture supernatants was assayed by the S+L-assay on mink cells or by the presence of reverse transcriptase activity (1).
RNase T1 fingerprints. Preparation of 32P-labeled viral RNA, its digestion with RNase T1, and separation of the resulting oligonucleotides by two-dimensional gel electrophoresis were performed as described previously (18) .
DNA sequencing. All DNA sequencing was performed as previously described, using M13mpl8 or M13mpl9 vectors (35) . Pathogenicity tests. Female AKR/J mice (40 to 45 days of age) were anesthetized by intraperitoneal injection of avertine (aqueous solution of 0.29 mg of 2,2,2,-tribromoethanol-160 mg of isoamyl alcohol per g of body weight). The thymus was exposed surgically as described previously (27) , and the left lobe was injected with virus or tissue culture medium as a control (0.05 ml per lobe normalized to 500 to 1,000 pmol per ml of reverse transcriptase activity, representing approximately 5 x 104 infectious units). Injected mice were observed for signs of frank leukemia (scruffled fur, hunched appearance with chest enlargement, labored breathing, lymph node enlargement). Induction of thymic lymphoma was confirmed by gross pathologic examination of affected tissues at necropsy. In some experiments, virus-injected mice were not observed after 180 days of age, at which time the incidence of spontaneous leukemia in AKR/J control mice becomes significant (24, 37, 38) . RESULTS Characterization of molecular clones of MCF 30-2. To define the viral genes that distinguish MCF 247 from MCF 30-2, the genomes of the viruses were compared by RNase T1 fingerprinting and restriction mapping. We used these techniques to reveal significant differences between the two viruses. Shown in Fig. 1 Fig. 1A and B) . Since these unique oligonucleotides are in separate genes, it is most likely that they represent single-base changes in the viral genomes. Conversely, a major oligonucleotide substitution was located in the pi5E region of the envelope gene (Fig. 1E) . Two Fig. 1E ).
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The enhancer-containing sequences of the two parental clones of MCF 247 (p247-W and p247-1b) were aligned with those of MCF 30-2 (Fig. 5) . We sequenced and compared the first copy of the direct repeat of MCF 247-W with that of the second as well as with those of MCF 247-lb and MCF 30-2. There are four nucleotide sequence differences among the enhancer sequences. The first copy of the direct repeat in MCF 247-W has a nucleotide transition (A to G). This transition occurs in the sequence which in Moloney MuLV binds the B-cell-specific enhancer-binding protein NF-KB (45, 48) . In addition, the first direct repeat of MCF 247-W has three additional nucleotides compared with the second copy (41, 49) . More recent studies demonstrate that the LTR functions to determine the leukemogenic potential of the viruses in vivo by mediating the rate of infection of the bursal target stem cell (2) . The timing of infection of thymocytes appears to affect the acceleration of leukemia in AKR mice as well (16) .
To determine whether the number of copies of the enhancer sequence affects the ability of MCF viruses to replicate in thymocytes, we quantitated and compared the number of infectious viral particles produced by thymocytes isolated from animals 48 days after injection with either MCF 30-2, MCF 247, or recombinant viruses. Since the assay for thymotropism was performed 48 days after intrathymic injection of the viruses, we recognize that the viruses or the recombinants might replicate to different titers early after injection. Figure 6 shows that MCF 30-2, MCF 247, and most of the recombinant viruses were thymotropic as measured by infectious center assay on S+L-mink cells. The only possible exception was recombinant 5 (30-2 + 247 lb LTR). Thymocytes isolated from three animals injected with recombinant 5 produced a low titer of virus. Thymocytes isolated from a fourth animal from that group produced a titer of virus approximately equal to that of the parents or other recombinants. We conclude from these data that MCF 30-2, MCF 247, and all the recombinants, including recombinant 5, are thymotropic.
In all cases, the frequency of infectious centers in thymocyte suspensions was low (0.01 to 0.1%), yet no infectious centers were detected in thymuses of control mice injected with tissue culture medium (<0.1/106 thymocytes). Despite the low level of productive infection, flow cytometric analysis of thymocytes stained with a monoclonal antibody that reacts with both ecotropic and MCF MuLV gp7os showed that, on the average, 64% of thymocytes expressed high levels of gp7O compared with thymocytes of control mice. The majority of thymocytes in MCF 30-2, MCF 247, and recombinant virus-injected mice were, in fact, infected at day 48 as judged by expression of viral antigen, a known characteristic of MuLV-infected lymphoid cells (19, 20, 36, 37) . These data confirm previous reports which demonstrate that the viral phenotypes of thymotropism and pathogenicity are clearly separable (37) . In the present work, we have demonstrated that oncogenicity is dependent on the number of copies of the retroviral enhancer sequences or on their specific sequences.
DISCUSSION
Evidence from studies of several retroviruses supports the hypothesis that the ability of a virus to replicate in the target tissue as well as the transformation potential of MuLVs are both controlled, at least in part, by sequences within the retroviral LTR (3, 5, 6, 12-14, 17, 24, 32, 33, 43, 46, 52) . The results of experiments presented here demonstrate that the enhancer sequences of MCF viruses are important determinants of the disease-inducing potential in these viruses. These studies extend previous reports demonstrating that the LTR of MCF 247 controls an in vitro tissue culture host range property of the virus that is correlated with the in vivo thymotropic phenotype (25) . Specifically, these data show that a single copy of the enhancer sequence is sufficient to establish the thymotropic phenotype of MCF (39, 53) , and polyomavirus have been presented previously (40, 44, 50) .
The number of enhancer sequences produces differential effects in MuLVs with distinct oncogenic or tissue tropic properties. It has been demonstrated that Friend or Moloney MuLV with one copy of the enhancer sequence induces disease with a longer latent period compared with viruses with two copies of the enhancer (17, 33, 47) . Conversely, separate experiments show that neither the number of copies nor the exact sequence of the enhancer determines either the latent period or the tissue specificity of spleen focus-forming virus (SFFV) (51) . Neither the disease specificity nor the latency of the disease was affected by the number of copies of the direct repeat or by the origin of the direct repeat (from Friend MuLV, Friend MCF, or Moloney MuLV). These experiments and others suggest that the env gene of SFFV is the primary determinant of the leukemogenicity of SFFV (51) . Taken together with our data, these results suggests that MCF viruses and some other replication-competent retroviruses transform the target cell by a different mechanism than that of SFFV. The mechanism of transformation of the replication-competent retroviruses might be dependent on a specific enhancer-controlled function, whereas viral genes of SFFV and other oncogene-containing replication-defective viruses transform the target cell more directly.
